2015
DOI: 10.3109/07388551.2014.990414
|View full text |Cite
|
Sign up to set email alerts
|

Nanodevices for the immobilization of therapeutic enzymes

Abstract: Therapeutic enzymes are one of the most promising applications of this century in the field of pharmaceutics. Biocatalyst properties can be improved by enzyme immobilization on nano-objects, thereby increasing stability and reusability and also enhancing the targeting to specific tissues and cells. Therapeutic biocatalyst-nanodevice complexes will provide new tools for the diagnosis and treatment of old and newly emerging pathologies. Among the advantages of this approach are the wide span and diverse range of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
39
0
2

Year Published

2017
2017
2020
2020

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 40 publications
(41 citation statements)
references
References 130 publications
0
39
0
2
Order By: Relevance
“…In fact, stability of PLGA based particles can be adjusted from weeks to years depending on the ratio of lactic and glycolic acid . However, future uses might as well include biomedical applications such as antigen immobilization on nanoparticulate carriers used for vaccination or immobilization of digestion enzymes like lactases or endopeptidases for the treatment of lactose intolerance or celiac disease . Preliminary experiments in the zebrafish embryo model indeed demonstrate enzymatic activity in a biological environment (i.e., the blood circulation of a vertebrate).…”
Section: Discussionmentioning
confidence: 99%
“…In fact, stability of PLGA based particles can be adjusted from weeks to years depending on the ratio of lactic and glycolic acid . However, future uses might as well include biomedical applications such as antigen immobilization on nanoparticulate carriers used for vaccination or immobilization of digestion enzymes like lactases or endopeptidases for the treatment of lactose intolerance or celiac disease . Preliminary experiments in the zebrafish embryo model indeed demonstrate enzymatic activity in a biological environment (i.e., the blood circulation of a vertebrate).…”
Section: Discussionmentioning
confidence: 99%
“…Nanoparticle devices and biolabels are novel gadgets for multifaceted applications ranging from bio‐ or nanomedicine to agriculture (Hauser, Maurer‐Stroh, & Martin, ; Holzinger, Goff, & Cosneir, ; Marazza, ; Verma & Bhardwaj, ; Vigneshvar et al., ). Nanoparticle devices provided flexibility to effectively use the biosensor for specific applications in drug delivery and disease diagnosis (Bosio, Islan, Martinez, Duran, & Castro, ; Holzinger et al., ; Vaddiraju, Tomozas, Burgess, Jain, & Papadimitrakopoulos, ) and in many other fields such as biodefence, food safety and pharmaceutics with technological combination of surface plasmon resonance (SPR) spectroscopy (Torun, Boyaci, Temür, & Tamer, ). Conversely, biolabels are novel tools of biosensors wherein targeted “electronic skin” detects chemical ingredients in physiological or security analysis in biomedicine or forensic science (Windmiller, Bandodkar, Parkhomovsky, & Wang, ; Windmiller, Bandodkar, Valdes‐Ramirez et al., ).…”
Section: Introductionmentioning
confidence: 99%
“…138) PEGylation has also been used to enhance systemic stability; avoid enzymatic degradation; opsonize; for non-selective accumulation; and to maintain the solubility and activity of proteins and, in some cases, the enhancement of cellular uptake. 142) In addition, the functionalization of PEGylated enzymes with specific ligands could enhance cell internalization, as recently demonstrated by PEGylated cytochrome P450 functionalized with folic acid. 106) The immunological response also can be overcome by encapsulating the enzyme within a protective nanoparticle, such as a liposome.…”
Section: Alternative Enzymatic Therapiesmentioning
confidence: 99%